Pollard-Knight Denise
Insider CIK 1297000 · IDIX Director · OMED Director · ALBO Director, 10% owner · MREO Chief Executive Officer, Director · ELAN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health Inc | A Award | 2026-05-21 | 2026-05-26 | 4,678 | — | $0 | 93,392 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2026-05-21 | 2026-05-26 | 12,196 | — | $0 | 105,588 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-01 | 2026-02-02 | 480,000 | — | $0 | 480,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-01 | 2026-02-02 | 1,035,000 | — | $0 | 1,035,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-01 | 2026-02-02 | 345,000 | — | $0 | 345,000 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2025-11-28 | 2025-12-02 | 10,314 | — | $0 | 88,714 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-01-25 | 2025-01-28 | 825,000 | — | $0 | 825,000 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2024-11-29 | 2024-12-03 | 18,169 | — | $0 | 78,400 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-09-13 | 2024-09-16 | 60,046 | $4.22 | $253.4K | 808,921 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-09-12 | 2024-09-16 | 28,611 | $4.47 | $127.9K | 868,967 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-09-11 | 2024-09-13 | 188,060 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-09-11 | 2024-09-13 | 188,060 | — | $0 | 897,578 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-06-26 | 2024-06-27 | 92,273 | $3.39 | $312.8K | 709,518 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-06-25 | 2024-06-27 | 40,712 | $3.69 | $150.2K | 801,791 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-06-21 | 2024-06-25 | 282,090 | — | $0 | 188,060 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-06-21 | 2024-06-25 | 282,090 | — | $0 | 842,503 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-01-25 | 2024-01-26 | 850,000 | — | $0 | 850,000 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2023-11-30 | 2023-12-04 | 20,374 | — | $0 | 60,231 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2022-11-30 | 2022-12-02 | 18,649 | — | $0 | 39,857 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2021-11-30 | 2021-12-02 | 7,307 | — | $0 | 21,208 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2020-11-30 | 2020-12-02 | 5,885 | — | $0 | 13,901 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2019-11-29 | 2019-12-02 | 5,233 | — | $0 | 8,016 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2019-04-11 | 2019-04-12 | 2,783 | — | $0 | 2,783 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-06-16 | 2017-06-20 | 3,000 | — | $0 | 3,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-01-23 | 2017-01-25 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2016-11-03 | 2016-11-07 | 1,165,447 | — | $0 | 1,165,447 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-31 | 2015-01-02 | 3,799 | $21.66 | $82.3K | 1,943,509 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-30 | 2014-12-30 | 5,510 | $21.65 | $119.3K | 1,947,308 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-29 | 2014-12-30 | 9,902 | $21.62 | $214.1K | 1,952,818 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-26 | 2014-12-30 | 2,195 | $21.65 | $47.5K | 1,962,720 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-19 | 2014-12-23 | 20,654 | $21.71 | $448.4K | 1,964,915 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-10 | 2014-12-10 | 7,940 | $21.77 | $172.9K | 1,985,569 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-09 | 2014-12-10 | 23,273 | $21.78 | $506.9K | 1,993,509 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-08 | 2014-12-10 | 1,727 | $21.68 | $37.4K | 2,016,782 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-05 | 2014-12-05 | 24,245 | $21.58 | $523.2K | 2,019,264 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-05 | 2014-12-05 | 755 | $22.10 | $16.7K | 2,018,509 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-30 | 2014-07-02 | 11,485 | $23.59 | $270.9K | 2,043,509 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-25 | 2014-06-27 | 3,252 | $23.56 | $76.6K | 2,054,994 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-24 | 2014-06-25 | 11,764 | $23.57 | $277.3K | 2,058,246 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-23 | 2014-06-25 | 52,797 | $24.20 | $1.28M | 2,070,010 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2014-06-05 | 2014-06-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 2,063,983 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 58,824 | $17.00 | $1.00M | 2,122,807 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 2,063,983 | — | $0 | 2,063,983 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-06-06 | 2013-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-06-07 | 2012-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |